Article
An environmental epigenetic study of ADRB 2 5′‐ UTR methylation and childhood asthma severity
18 Jun 2012
Abstract excerpt
BACKGROUND: Beta-2 adrenergic receptor (ADRB2) is the primary target of both short- and long-acting beta-agonist asthma medications. ADRB2 5'-UTR methylation changes in blood have the potential to act as a surrogate biomarker of responsiveness to beta-agonist treatment and childhood asthma severity. OBJECTIVE: To study the association between ADRB2 5'-UTR methylation, NO (2) exposure and childhood asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
